Investors Title

Investors Title paid $14.00 a share in special dividends in 2024, and the stock still trades at 15.8x earnings.

If you own ITIC, this is what matters for your cash.

itic

financials small cap updated jan 16, 2026
$254.61
market cap ~$421M · 52-week range $190–$289
xvary composite: 56 / 100 · below average
our overall rating — combines growth, value, risk, and momentum
Start here if you're new
what it is
It sells title insurance and related closing services, plus trust and exchange work, to real-estate customers.
how it gets paid
Last year Investors Title made $35M in revenue. title insurance was the main engine at $30M, or 86% of sales.
what just happened
The latest quarter put $31M of revenue on the board, with EPS at $14.59.
At a glance
B+ balance sheet — decent shape, but not bulletproof
45/100 earnings predictability — expect surprises
15.8x trailing p/e — the market's not buying it — or you found a deal
0.8% dividend yield — cash in your pocket every quarter
$16.43 fy2024 eps est
xvary composite: 56/100 — below average
What they do
It sells title insurance and related closing services, plus trust and exchange work, to real-estate customers.
Real-estate closings are messy, and Investors Title lives inside that mess. It has 521 employees across 3 service lines, so you are buying a niche gatekeeper, not a broad insurer.
financials small-cap insurance real-estate dividend
How they make money
$35M annual revenue
title insurance
$30M
+178.0%
tax-deferred exchange services
$3M
+4.0%
trust and management services
$2M
+0.0%
The products that matter
underwrites property title policies
Title Insurance
$273M · about 95% of shown segment revenue
This is the business. It accounts for roughly $273M of revenue in the snapshot, so your thesis lives or dies on real estate closings and premium volume.
core driver
facilitates tax-deferred exchanges
1031 Exchange Services
$14M · about 5% of shown segment revenue
This is a real business, just not a large one. At $14M, it adds diversification, but it is nowhere near big enough to offset weakness in title insurance.
small but useful
Key numbers
$254.61
share price
At $254.61, the market already prices in a lot of the good news.
15.8x
trailing p/e
You pay 15.8 times earnings for a tiny insurer, which is fair rather than cheap.
0.8%
dividend yield
The regular payout is tiny. The real cash has come from specials.
1.05
beta
A 1.05 beta means the stock should move a bit more than the market.
Financial health
B+
strength
  • balance sheet grade B+ — solid but not elite
  • risk rank 3 — safer than 50% of stocks
  • price stability 65 / 100
B+ — functional but not a standout on the balance sheet.
Total return vs. market

Return history isn't available for ITIC right now.

source: institutional data · return history unavailable
What just happened
beat estimates
The latest quarter put $31M of revenue on the board, with EPS at $14.59.
Revenue was up 178% vs. prior year, and EPS rose 126%. Profit margin was 12.9%, which is lean for a tiny insurer but still positive.
$31.0M
revenue
$14.59
eps
12.9%
profit margin
revenue jump
The 178% revenue jump mattered most, because the company is only a $421M stock and every closing shows up fast.
source: company earnings report, 2026

Get this snapshot in your inbox

This page, delivered free — plus weekly updates when the numbers change. plain english, no spam.

weekly updates earnings alerts plain english no spam
What could go wrong

the top risk here is title premium pressure from a weak real estate closing market.

!
high
title premium pressure
Management already tied weaker q4 earnings to lower premium income. With Title Insurance representing roughly $273M of the shown segment revenue, this is the business risk.
If premium volume stays soft, most of the company's revenue base stays exposed.
!
high
internal control and fraud-monitoring scrutiny
A June 2024 SEC filing flagged the risk of not detecting a material misstatement from fraud. That does not mean fraud happened. It does mean the company said the risk out loud.
Any follow-up disclosure or control failure would hit trust first and valuation second.
med
multi-year earnings erosion
Earnings are down 19.1% over multiple years. That is the part value investors love to call temporary right before it lasts longer than expected.
If the decline continues, the current multiple probably does not expand.
med
business concentration
The 1031 exchange segment is only $14M in revenue. That leaves Investors Title heavily dependent on one core line of business.
There is not much diversification to cushion a slowdown in title activity.
Most of the risk stack comes back to one fact: roughly $273M of revenue sits in title insurance, and that revenue already showed pressure through lower premium income.
source: institutional data · regulatory filings · risk analysis
Pay attention to
metric
premium income direction
Management already blamed lower premium income for the q4 decline. If that line stabilizes, the earnings story can stabilize with it.
risk
any follow-up to the 2024 control disclosure
The June 2024 fraud-risk language is specific enough that you should watch future filings for changes, remediation, or silence.
calendar
next quarterly earnings print
One down quarter can happen. A repeated drop from the $4.41 to $3.97 pattern starts to confirm the broader earnings slide.
trend
whether 1031 services stays too small to matter
At $14M, this segment is not moving the whole company today. If it remains tiny, Investors Title stays tied almost entirely to title insurance.
Analyst rankings
earnings predictability
45 / 100
This score says earnings are harder to model than average. In human-speak, analysts do not trust this company to deliver the same script every quarter.
balance sheet grade
B+
The balance sheet looks fine. It just does not compensate for a business profile that depends heavily on transaction volume.
source: institutional data
Institutional activity

institutional ownership data for ITIC is being compiled.

source: institutional data
Price targets
3-5 year target range
n/a n/a
$255 current price
n/a target midpoint · n/a from current
target data not available

Want the deeper analysis?

The full deep dive: dcf model, scenario analysis, competitive moat breakdown, and quarterly tracking — everything on this page, taken further.

see plans from $5/mo
The deep dive
ITIC
xvary deep dive
itic
the full analysis is in the works.
what you'll get
dcf valuation model
bull / base / bear scenarios
competitive moat breakdown
quarterly earnings tracker
operating model projections
risk matrix with kill criteria
original price target + conviction
updated with every earnings
free · no spam · you'll be first to read it